Johnson & Johnson Segmentwise Revenue
Segmentwise Revenue of Johnson & Johnson 2009-2021
Amounts are in $million.
| Year | Consumer | Pharmaceutical | Medical devices |
| 2021 | $14,635 | $52,080 | $27,060 |
| 2020 | $14,053 | $45,572 | $22,959 |
| 2019 | $13,898 | $42,198 | $25,963 |
| 2018 | $13,853 | $40,734 | $26,994 |
| 2017 | 13,602 | 36,256 | 26,592 |
| 2016 | 13,307 | 33,464 | 25,119 |
| 2015 | 13,507 | 31,430 | 25,137 |
| 2014 | 14,496 | 32,313 | 27,522 |
| 2013 | 14,697 | 28,125 | 28,490 |
| 2012 | 14,447 | 25,351 | 27,426 |
| 2011 | 14,883 | 24,368 | 25,779 |
| 2010 | 14,590 | 22,396 | 24,601 |
| 2009 | 15,803 | 22,520 | 23,574 |
2021: The pharmaceutical segment of Johnson and Johnson generated $52,080 million in 2021 compared to $45,572 million in 2020. The company generated $27,060 million in net revenues from the medical devices segment compared to $22,959 million in 2020. Its net sales from the consumer segment were $14,635 million in 2021 compared to $14,053 million in 2020. The total net revenues of the company in 2021 increased to $93,775 million compared to $82,584 million in 2020.
Pharmaceutical is the largest business segment of Johnson and Johnson followed by Medical devices and consumer segment. In 2018, the revenue of Johnson & Johnson from Pharmaceutical was $40,734 million and that from medical devices was $26,994 million while the consumer segment generated $13,853 million.